Get an alert when GLAXOSMITHKLINE CARIBBEAN LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-08-18 (in 3mo)

Last made up 2025-08-04

Watchouts

None on the register

Cash

£2M

-9.5% vs 2023

Net assets

£39M

+2.4% vs 2023

Employees

21

-25% vs 2023

Profit before tax

£728K

+11.1% vs 2023

Name history

Renamed 2 times since incorporation

  1. GLAXOSMITHKLINE CARIBBEAN LIMITED 2002-01-29 → present
  2. SMITHKLINE BEECHAM CARIBBEAN LIMITED 1995-12-18 → 2002-01-29
  3. STERLING DRUG INTERNATIONAL LIMITED 1953-07-28 → 1995-12-18

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £16,516,000£18,016,000
Operating profit -£683,000-£787,000
Profit before tax £655,000£728,000
Net profit £313,000£843,000
Cash £2,612,000£2,363,000
Total assets less current liabilities £37,866,000£38,871,000
Net assets £37,593,000£38,507,000
Equity £37,593,000£38,507,000
Average employees 2821
Wages £1,899,000£2,451,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin -4.1%-4.4%
Net margin 1.9%4.7%
Return on capital employed -1.8%-2.0%
Gearing (liabilities / total assets) 8.8%10.1%
Current ratio 2.19x2.46x
Interest cover -21.34x-18.30x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Auditor
Deloitte LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“Having assessed the principal risks of the Company and other matters, the Directors are of the opinion that the current level of activity remains sustainable. The Directors in their considerations have included the potential risks to customer demand and operational risks to distribution channels. The Directors have considered the Company's ability to continue as a going concern for a minimum of twelve months from the date of signing of these financial statements. The Directors have taken into account that as part of the Group, the Company has the support from the Group through the access to the Group cash pooling mechanism and can take actions to ensure business continuity through operational channels, as well as the ability to manage variable costs. On the basis of those considerations, the Directors believe that it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”

Group structure

  1. GLAXOSMITHKLINE CARIBBEAN LIMITED · parent
    1. GlaxoSmithKline Caribbean Limited - Jamaica 1% · Jamaica · sale of pharmaceutical products
    2. GlaxoSmithKline Caribbean Limited - Trinidad and Tobago 1% · Trinidad and Tobago · sale of pharmaceutical products

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 29 resigned

Name Role Appointed Born Nationality
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED Corporate Secretary 2002-01-18
RIVERS, Graham Paul Director 2020-03-02 May 1971 British
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED Corporate Director 2001-03-15
GLAXO GROUP LIMITED Corporate Director 2001-03-15
Show 29 resigned officers
Name Role Appointed Resigned
ADAMS, Deborah Anne Secretary 1995-05-10 1996-01-17
BANKS, Valerie Secretary 1996-01-17 1998-05-18
BRYANT, Karina Jane Secretary 1999-12-22 2002-01-18
COOMBER, Caroline Daphne Secretary 1998-05-18 1999-12-22
COULES, Lindsey Janice Secretary 1995-05-10 1997-04-03
MCBARRON, Paul Kevin Secretary 1994-08-01
PILKINGTON, Valerie Secretary 1995-05-10 1996-01-17
WALSH, Michael Martin Secretary 1994-08-01 1995-05-10
ANDREWS, Charles James Director 1998-04-08 2001-03-16
BLACKBURN, Paul Frederick Director 2009-09-09 2016-03-01
BONDY, Rupert Director 1995-11-30 2001-03-16
GOODWIN, Herbert Ashley Director 1992-08-28
GRUMITT, John Paul George Director 1996-09-19 1998-04-08
HANNAN, Mark Director 1994-09-06 1999-07-06
HORLER, Alison Marie Director 1994-11-01 1995-08-30
LOPEZ, Guillermo Director 1994-08-01 1999-03-31
LUCKHAM, Anthony Arthur Director 1995-08-30 1996-09-19
MCBARRON, Paul Kevin Director 1994-08-01
MCCLINTOCK, Clare Alexandra Director 2000-01-01 2001-03-16
MCCLINTOCK, Clare Alexandra Director 1994-11-01 1995-08-30
OSBORN, David Director 1996-09-19 2001-03-16
PANAGIOTIDIS, Charalampos Director 2019-02-15 2020-03-02
SAUNDERS, John Barry Director 1994-11-01 1995-11-30
SAUREZ, Frederick Director 1994-08-01
STEVENS, David John Director 1994-11-01 1995-03-10
SUTHERLAND, Marcia Director 1994-08-01 1999-09-24
TANG, Norman Willan Director 1994-08-01
WALKER, Adam Director 2015-09-14 2020-03-02
WALSH, Michael Martin Director 1994-08-01 1995-06-30

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Smithkline Beecham Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Active

Filing timeline

Last 20 of 190 total filings

Date Type Category Description
2025-08-14 AA accounts Accounts with accounts type full
2025-08-04 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-09-17 CH01 officers Change person director company with change date PDF
2024-09-11 PSC05 persons-with-significant-control Change to a person with significant control PDF
2024-09-11 AD01 address Change registered office address company with date old address new address PDF
2024-08-16 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-07-24 AA accounts Accounts with accounts type full
2024-07-18 AD02 address Change sail address company with new address PDF
2023-10-06 AA accounts Accounts with accounts type full
2023-08-16 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-08-16 CH02 officers Change corporate director company with change date PDF
2022-10-13 AA accounts Accounts with accounts type full
2022-08-18 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-10-22 AA accounts Accounts with accounts type full
2021-08-10 CS01 confirmation-statement Confirmation statement with no updates PDF
2020-10-13 AA accounts Accounts with accounts type full
2020-08-25 CS01 confirmation-statement Confirmation statement with no updates PDF
2020-07-02 TM01 officers Termination director company with name termination date PDF
2020-05-11 AP01 officers Appoint person director company with name date PDF
2020-03-17 TM01 officers Termination director company with name termination date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page